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There are abundant of biological resources in ocean and marine organisms which contain a lot of novel compounds. With the reduction of the scope of development and exploration of terrestrial biological resources of medicine, people have to cast their sights on the ocean with a hope to find and develop antitumor drugs with low toxicity and high efficacy from marine organisms. Hirsutanol A is a sesquiterpene compound which is isolated from fungus sp in from the South China Sea coral, the chemical structure of which has been reported only once [1] and its pharmacological activity has not been reported yet. We have detected the cytotoxic activity of six compounds extracted from marine organisms and found that Hirsutanol A had obvious cytotoxicity. Reactive oxygen species (ROS), a class of single electron reduction products of oxygen in vivo, are generated by electrons which leak from respiratory chain and consume about 2% of the oxygen before electrons are transmitted to the terminal oxidase. ROS can induce apoptosis and autophagy in tumor cells. On the one hand, autophagy can provide energy for cells by degrading their own damaged organelles to protect cells from death. On the other hand, excessive autophagy can cause autophagic cell death. Due to a longterm highlevel of ROS, the redox system of tumor cells are more vulnerable than that of normal cells. Treating cells with the drugs which can increase ROS levels would selectively kill tumor cells sparing normal cells. The redox system of cells is considered to be a new target for antitumor drugs [2, 3] . Hirsutanol A has an unsaturated carbonyl. Analyzing the chemical structure, the compound has a strong oxidative effect. We speculated that the compound may induce apoptosis or autophagic cell death of tumor cells by elevating ROS. This study mainly investigated the effect of Hirsutanol A on ROS levels in hepatocellular carcinoma (HCC) cells and autophagic cell death caused by elevating ROS levels. It provided a basis for further clarification of the antitumor mechanisms of Hirsutanol A and provided novel lead compound for developing antitumor drugs with high efficacy and low toxicity targeting the redox system. Figure 1 . Hep3B, Bel7402, CNE2, A549, SW480, LOVO, and HeLa cells in logarithmic phase were seeded into 96well plates at a density of 600010000 cells per well in 195 滋 L, each with 4 parallel wells, then 5 滋 L of Hirsutanol A at different concentrations was added to each well; Hep3B cells were pretreated with 10 mmol/L 3MA [4, 5] or 1 mmol/L NAC [6] for 1 h followed by incubation at 37益 for 72 h. A total of 10 滋 L of 5 mg/mL MTT was added 4 h before the termination of the experiment. Afterwards, culture medium were removed and 100 滋 L of DMSO was added. value of each well at a wavelength of 570 nm was detected with the microplate reader (BIORAD Model 550) after the crystal was dissolved. The rates of cell growth inhibition were calculated. The 50% inhibitory rates (% ) were then calculated by the BLISS method: 50% inhibitory rate = (1 the average value of treatment group / the average value of the control group) 伊 100%.
Hep3B cells were diluted to 3.0 伊 10 5 per mL and seeded into 6well plates. Hep3B cells were treated with 20 滋 mol/L Hirsutanol A for different times, or pretreated with NAC for 1 h and then treated with 20 滋 mol/L Hirsutanol A for 24 h. Cells were colletecd and washed with PBS twice, 100 滋 L cell lysate was added and centrifuged at 14 000 r/min for 10 min. Proteins were quantified. After loading buffer was added to cell lysate, samples were denatured for 10 min at 95益 . SDS polyacrylamide gel (10% 15% ) electrophoresis was carried out and the protein was transferred to PVDF membrane. After blocked with 5% nonfat milk, the primary and secondary antibodies were added successively. The membrane was incubated at room temperature for 2 h and washed with TBST buffer 3 times for 10 min each. ECL was added, then the membrane was put in the cassette and pressed with a film for 25 min followed by developing and fixing.
Hep3B cells were diluted to 2.0 伊 10 5 /mL and seeded into 6well plates with 2 mL in each well. Cells were treated with 20 滋 mol/L Hirsutanol A for different times, or treated with Hirsutanol A at different concentrations for 24 h. Then, 1 滋 mol/L (final concentration) CMH2DCFDA fluorescent dye was added and the cells were incubated at 37益 in dark for 1 h. After washed in 4益 PBS twice, cells were centrifuged and resuspended with PBS. Flow cytometer (BECKMAN COULTET FC500) with FACS Calibur system with CellQuestPro was used to detect intracellular ROS Chemotherapy is one of the three major treatment means of tumor. Therefore, developing new and effective anticancer drugs is still the main strategy to conquer tumor. Due to the particularity of their living environments (high pressure, hypoxia, high salt, and so on), marine organisms often contain a large number of metabolites with novel structure and significant physiologic activity. Therefore, to find natural medicine with highefficacy and low toxicity from marine organisms has attracted increasing international interest. A large number of natural products with significant antitumor, antibacterial, antiviral, and antioxidant activities have been isolated, most of which have never been found in terrestrial organisms. For example, the leads of antitumor and antiviral drugs cytosine arabinoside A and C, which were widely used clinically, were isolated from the sp [8] . We have screened 6 compounds isolated from marine organisms in terms of antitumor effect and found that Hirsutanol A has obvious cytotoxicity. Hirsutanol A is a sesquiterpene compound isolated from fungus sp in in the South China Sea coral. It is isolated from a new microbial strain, the pharmacological activity has not been reported. Therefore, we further explored its antitumor effects and its mechanisms.
ROS, a class of single electron reduction products of oxygen in vivo, are generated by electrons which leak from respiratory chain and consume about 2% of the oxygen before electrons are transmitted to the terminal oxidase, including oneelectron reduzate要oxygen superoxide anions (O 2 ), twoelectron reduzate要hydrogen peroxide (H 2 O 2 ), threeelectron reduzate要hydroxyl radical (OH), nitric oxide, and so on. The generation of ROS is closely associated with tumorigenesis and treatment. ROS is a twoedged sword. On the one hand, an abnormal increase of ROS can promote tumorigenesis; on the other hand, excessive increase of ROS can induce apoptosis and autophagic death of tumor cells, result in cancer cell growth inhibition [9, 10] . In the present study, we found that Hirsutanol A could induce Hep3B cells to produce ROS and ROS scavenger NAC could significantly prevent Hirsutanol Ainduced cell death.
LC3 is the mammalian homologue of yeast Atg8, locates on the membrane surface of preautophagosomes and autophagic vacuoles. It is a common marker for autophagic vacuolar membranes. Newly synthesized LC3 in cells becomes cytoplasmic soluble LC3I after process. After ubiquitinlike modification, LC3I combines with phosphatidyl ethanolamine (PE) which is located on the membrane surface of autophagic vacuoles, known as LC3II. The content of LC3II is positively related to the number of autophagic vacuoles. Therefore, changes of the content of LC3II reflect the autophagic activity of the cells to some extent [11, 12] . Hirsutanol A can induce LC3II expression. After treatment with ROS scavenger NAC, the conversion of LC3 from type I to type II reduced, suggesting that Hirsutanol A induced HCC cells to undergo autophagy by increasing ROS. PI3K is the enzyme family which catalyzes phosphorylation of inositol group of membrane phosphoinositide. According to structural subunits and characteristics of substrates, PI3K can be divided into types I, II and III, of which type III phosphoinositide 3 kinase (PI3KC3) is a mammalian homologue of yeast Vps34. PI3KC3 forms compounds with Beclin 1, Vps15, and so on, and plays a necessary role in the initial stage of autophagic vesicle formation and the transport process of transferring cell contents to the lysosome [13] . PI3KC3 inhibitor 3MA can inhibit the occurrence of autophagy effectively in the initial stage of autophagy. When blocked autophagy with 3MA, Hirsutanol Ainduced cell death significantly reduced, suggesting that Hirsutanol A induced autophagic cell death of Hep3B cells by the induction of ROS. Hirsutanol A has a new chemical structure with antitumor activity. Its antitumor mechanisms in vitro and in vivo remain to be studied in the future.
